Prana Biotechnology Limited (ADR)  

(Public, NASDAQ:PRAN)   Watch this stock  
Find more results for PRAN
2.17
-0.01 (-0.43%)
Feb 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.15 - 2.27
52 week 1.52 - 6.69
Open 2.16
Vol / Avg. 4,758.00/25,471.00
Mkt cap 20.77M
P/E     -
Div/yield     -
EPS -4.00
Shares 88.98M
Beta 0.17
Inst. own 0%

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin -7461.70% -5418.16%
Operating margin -9759.36% -9351.25%
EBITD margin - -9335.26%
Return on average assets -26.89% -20.46%
Return on average equity -28.76% -21.93%
Employees 15 -
CDP Score - -

Address

L 2 369 Royal Pde
MELBOURNE, VIC 3052
Australia
+61-3-93494906 (Phone)
+61-3-93480377 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Prana Biotechnology Limited is a development-stage medical biotechnology company. The Company is engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. The Company's lead product candidates are PBT2 and PBT434. The Company's lead drug candidate PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. The Company also has advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing. Its other applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease (the human variant of Mad Cow disease), and a range of orphan neurodegenerative disorders.

Officers and directors

Geoffrey Paul Kempler Executive Chairman of the Board, Chief Executive Officer
Bio & Compensation  - Reuters
Kathryn Andrews Chief Financial Officer
Bio & Compensation  - Reuters
Dianne Angus Chief Operating Officer
Bio & Compensation  - Reuters
Phillip Hains Company Secretary
Bio & Compensation  - Reuters
Ira Shoulson Non-Executive Independent Director
Bio & Compensation  - Reuters
Lawrence Gozlan Non-Executive Independent Director
Bio & Compensation  - Reuters
Peter Ashley Marks Non-Executive Independent Director
Bio & Compensation  - Reuters
Brian Derek Meltzer Non-Executive Independent Director
Bio & Compensation  - Reuters
George William Mihaly Non-Executive Independent Director
Bio & Compensation  - Reuters